The domestic and national PCR Diagnosis and Variant Analysis Kit of the TRNC, approved for use by the Ministry of Health, can simultaneously detect the UK, South Africa, Brazil and India variants of SARS-CoV-2, along with the diagnosis of COVID-19, within 1 hour.

The PCR Diagnosis and Variant Analysis Kit, designed and developed by Near East University scientists, has been approved for use by the TRNC Ministry of Health. The PCR Diagnosis and Variant Analysis Kit, developed to detect COVID-19 disease caused by SARS-CoV-2, detects the presence of SARS-CoV-2 in less than an hour, while at the same time Alpha (UK), Beta (South Africa), Gamma (Brazil) and Delta (India) variants can be typed.

With the approval of the SARS-CoV-2 PCR Diagnosis and Variant Analysis Kit, which was designed entirely by the Near East University scientists, by the Ministry of Health of the Turkish Republic of Northern Cyprus, a reliable and accurate domestic alternative to the test kits imported by the TRNC from abroad has now been produced.

Achieved 100 percent success in comparative tests
The R&D and design process of the PCR Diagnosis and Variant Analysis Kit, on which Near East University scientists have been working for a long time, was completed in February. Continuing optimization studies and safety and sensitivity tests of the kit were completed and it was ready for production.

The results of the TRNC's native PCR Diagnosis and Variant Analysis Kit, which was subjected to many comparative tests to measure its reliability, sensitivity, and accuracy in the laboratories of Near East University, were also confirmed by comparing it with the results of the commercial kits currently used in the market. As a result of comparative analyzes with different kits, it has been proven that the developed kit works with 100 percent sensitivity and accuracy.

The TRNC Minister of Health Dt. Ünal Üstel: “The PCR Diagnosis and Variant Analysis Kit, developed by Near East University, has all the necessary features for use with its high sensitivity, accuracy and reliability”
Announcing that they approved the use of the PCR Diagnosis and Variant Analysis Kit developed by Near East University, the TRNC Minister of Health Dt. Ünal Üstel said, “As a result of our evaluation, we are very pleased to see that the PCR Diagnosis and Variant Analysis Kit developed by Near East University has all the necessary features to be used in the detection of COVID-19, with its high sensitivity and reliability.” Reminding that variant analyzes of SARS-CoV-2, which causes COVID-19, are very important to keep the pandemic under control, Minister of Health Üstel said, “The PCR Diagnosis and Variant Analysis Kit, developed by Near East University and can diagnose the Alpha, Delta, Beta and Gamma variants simultaneously will provide a great advantage in the fight against the Covid-19 pandemic."

Prof. Dr. İrfan Suat Günsel: “It is a great honor for us to serve our country by producing the TRNC's domestic PCR Diagnosis and Variant Analysis Kit in the fight against COVID-19”
Near East Enterprises Chairman of the Board of Trustees Prof. Dr. İrfan Suat Günsel said that the PCR Diagnosis and Variant Analysis Kit, developed by Near East University, is one of the most comprehensive variant analysis kits among the kits used commercially around the world. Prof. Dr. Günsel said, “The PCR Diagnosis and Variant Analysis Kit, which we designed in our own research laboratories, gives results in as little as 1 hour, quickly, safely, accurately and with 100 percent sensitivity. It is a great honor for us to serve our country by producing the TRNC's native PCR Diagnosis and Variant Analysis Kit in the fight against COVID-19.

Explaining that the necessary approvals and permissions have been obtained from the Ministry of Health for the use of the Near East University PCR Diagnosis and Variant Analysis Kit, Prof. Dr. İrfan Suat Günsel said, “All our preparations for the production of the domestic PCR Diagnosis and Variant Analysis Kit have been completed. We will make it available domestically in the first place. In the next stage, we would like to bring the PCR Diagnosis and Variant Analysis Kit into use in abroad, especially in Turkey.”